Literature DB >> 24696311

Genetic analysis in Bartter syndrome from India.

Pradeep Kumar Sharma1, Bhaskar Saikia, Rachna Sharma, Kumar Ankur, Praveen Khilnani, Vinay Kumar Aggarwal, Hae Cheong.   

Abstract

Bartter syndrome is a group of inherited, salt-losing tubulopathies presenting as hypokalemic metabolic alkalosis with normotensive hyperreninemia and hyperaldosteronism. Around 150 cases have been reported in literature till now. Mutations leading to salt losing tubulopathies are not routinely tested in Indian population. The authors have done the genetic analysis for the first time in the Bartter syndrome on two cases from India. First case was antenatal Bartter syndrome presenting with massive polyuria and hyperkalemia. Mutational analysis revealed compound heterozygous mutations in KCNJ1(ROMK) gene [p(Leu220Phe), p(Thr191Pro)]. Second case had a phenotypic presentation of classical Bartter syndrome however, genetic analysis revealed only heterozygous novel mutation in SLC12A gene p(Ala232Thr). Bartter syndrome is a clinical diagnosis and genetic analysis is recommended for prognostication and genetic counseling.

Entities:  

Mesh:

Year:  2014        PMID: 24696311     DOI: 10.1007/s12098-014-1379-6

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  10 in total

1.  Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome.

Authors:  F C BARTTER; P PRONOVE; J R GILL; R C MACCARDLE
Journal:  Am J Med       Date:  1962-12       Impact factor: 4.965

Review 2.  Understanding Bartter syndrome and Gitelman syndrome.

Authors:  Oliver T Fremont; James C M Chan
Journal:  World J Pediatr       Date:  2012-01-27       Impact factor: 2.764

3.  Long-term follow-up of patients with Bartter syndrome type I and II.

Authors:  Elena Puricelli; Alberto Bettinelli; Nicolò Borsa; Francesca Sironi; Camilla Mattiello; Fabiana Tammaro; Silvana Tedeschi; Mario G Bianchetti
Journal:  Nephrol Dial Transplant       Date:  2010-03-10       Impact factor: 5.992

Review 4.  Bartter syndrome: an overview.

Authors:  I Amirlak; K P Dawson
Journal:  QJM       Date:  2000-04

5.  Two novel mutations of the gene for Kir 1.1 (ROMK) in neonatal Bartter syndrome.

Authors:  M Vollmer; M Koehrer; R Topaloglu; B Strahm; H Omran; F Hildebrandt
Journal:  Pediatr Nephrol       Date:  1998-01       Impact factor: 3.714

6.  Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies.

Authors:  Melanie Peters; Nikola Jeck; Stephan Reinalter; Andreas Leonhardt; Burkhard Tönshoff; G ünter Klaus G; Martin Konrad; Hannsjörg W Seyberth
Journal:  Am J Med       Date:  2002-02-15       Impact factor: 4.965

Review 7.  An improved terminology and classification of Bartter-like syndromes.

Authors:  Hannsjörg W Seyberth
Journal:  Nat Clin Pract Nephrol       Date:  2008-08-12

8.  Bartter syndrome: benefits and side effects of long-term treatment.

Authors:  Maria Helena Vaisbich; Maria Danisi Fujimura; Vera H Koch
Journal:  Pediatr Nephrol       Date:  2004-06-16       Impact factor: 3.714

9.  Indomethacin-induced colon perforation in Bartter's syndrome.

Authors:  Emel Ataoglu; Mahmut Civilibal; Ayse Ayaz Ozkul; Ipek Guney Varal; Elmas Reyhan Oktay; Elevli Murat
Journal:  Indian J Pediatr       Date:  2009-04-06       Impact factor: 1.967

10.  Childhood Bartter's syndrome: An Indian case series.

Authors:  K Sampathkumar; U Muralidharan; A Kannan; M Ramakrishnan; R Ajeshkumar
Journal:  Indian J Nephrol       Date:  2010-10
  10 in total
  1 in total

1.  Whole-exome sequencing and variant spectrum in children with suspected inherited renal tubular disorder: the East India Tubulopathy Gene Study.

Authors:  Rajiv Sinha; Subal Pradhan; Sushmita Banerjee; Afsana Jahan; Shakil Akhtar; Amitava Pahari; Sumantra Raut; Prince Parakh; Surupa Basu; Priyanka Srivastava; Snehamayee Nayak; S G Thenral; V Ramprasad; Emma Ashton; Detlef Bockenhauer; Kausik Mandal
Journal:  Pediatr Nephrol       Date:  2022-01-10       Impact factor: 3.651

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.